State Board of Pharmacy - Prohibition on Discrimination Against 340B Drug Distribution

This Maryland law prohibits drug manufacturers, wholesalers, and logistics providers from discriminating against pharmacies that are authorized to receive discounted 340B drugs on behalf of covered entities. The bill makes it an unfair trade practice to deny or restrict the acquisition or delivery of these discounted medications, with the exception of cases where federal law explicitly forbids the transfer. Violations can result in fines up to $5,000 per package, license discipline by the State Board of Pharmacy, or investigation by the Attorney General's Consumer Protection Division. Additionally, the Maryland Prescription Drug Affordability Board is tasked with studying the state's 340B program implementation, financials, and the impact of these new protections.